Login to Your Account



FDA Panel Wrestles with Biomarker Label Concerns

By Donna Young


Wednesday, December 17, 2008
GAITHERSBURG, Md. - While federal advisers shared numerous opinions Tuesday with drug regulators about the types and amounts of data needed to support product labeling using biomarkers, the panelists reached no clear consensus. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription